Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
Clinical trial NCT01141309 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01141309
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.